Beispiel: Heart Attack

Klinische Studien gesponsert von BioTech Tools S.A

Insgesamt 7 ergebnisse

NCT02560948

Abgeschlossen

Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

Bedingungen: Hay Fever
NCT02156791

Abgeschlossen

Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM

Bedingungen: Hay Fever
NCT01506375

Abgeschlossen

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

Bedingungen: Hay Fever
NCT01308021

Abgeschlossen

Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis

Bedingungen: Grass Pollen Allergy; Hay Fever
NCT01111279

Abgeschlossen

Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis

Bedingungen: Seasonal Allergic Rhinoconjunctivitis
NCT00833066

Abgeschlossen

Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis

Bedingungen: Seasonal Allergic Rhinoconjunctivitis
NCT00813046

Abgeschlossen

Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis

Bedingungen: Seasonal Allergic Rhinoconjunctivitis